Numan
United Kingdom
- London, England
- 07/02/2022
- Series B
- $60,100,000
We're on a mission to fix ill health for men where they feel it most. It’s a decades-old problem: men aren’t seeking the healthcare that they need. Our survey revealed that 4 out of 10 men haven’t visited a doctor in over a year, and 1 out of 10 can’t even remember the last time they saw a doctor. We help solve the issues that men often leave untreated - not the life-threatening stuff, but the kinds of health problems that can be swept under the rug and may not be outwardly visible.
We're a digital health platform for men - providing access to expert advice, medication, diagnostics and supplements.
At Numan, we help men do something about their health, and live longer, healthier lives.
- Industry Wellness and Fitness Services
- Website https://www.numan.com/
- LinkedIn https://www.linkedin.com/company/numan-com/about/
Related People
Sokratis PapafloratosFounder
United Kingdom -
London, England
Technology entrepreneur and angel investor.
Juvena Therapeutics | $33,500,000 | (Jan 14, 2026)
bricks.sh | $1,863,303 | (Jan 14, 2026)
Allos | $5,000,000 | (Jan 14, 2026)
PayMedix | $33,000,000 | (Jan 14, 2026)
WeatherPromise | $12,800,000 | (Jan 14, 2026)
Diffraqtion | $4,200,000 | (Jan 14, 2026)
WithCoverage | $42,000,000 | (Jan 14, 2026)
Nodu | $1,450,000 | (Jan 14, 2026)
Cloudforce | $10,000,000 | (Jan 14, 2026)
Converge Bio | $25,000,000 | (Jan 14, 2026)
JetZero | $175,000,000 | (Jan 14, 2026)
TRYBE | $30,000,000 | (Jan 13, 2026)